Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
CNBC ·
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
1 sources · 1 articles · updated 2026-11-06 11:47 UTC · business